⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Breckenridge Pharmaceutical, Inc.: Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrell

DrugsSource: FDA (drug) · Date: 2025-12-10

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Breckenridge Pharmaceutical

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Breckenridge Pharmaceutical, Inc.
Product
Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.
Reason / hazard
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide within the United States
Recall initiated
2025-11-24
Code info
Lot #: 240534C, Exp. Date 01/2027; 240977C, Exp. Date 04/2027.
Product quantity
7389 bottles
Voluntary mandated
Voluntary: Firm initiated
City
Berkeley Heights
State
NJ
Country
United States
Event id
98034
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.